AAAAAA

   
Results: 1-11 |
Results: 11
Immunoprecipitation and liquid chromatographic-mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP(1-42) and GIP(3-42) from human plasma samples - New sensitive method to analyzephysiological concentrations of peptide hormones
Authors: Wolf, R Rosche, F Hoffmann, T Demuth, HU
Citation: R. Wolf et al., Immunoprecipitation and liquid chromatographic-mass spectrometric determination of the peptide glucose-dependent insulinotropic polypeptides GIP(1-42) and GIP(3-42) from human plasma samples - New sensitive method to analyzephysiological concentrations of peptide hormones, J CHROMAT A, 926(1), 2001, pp. 21-27
Effect of aging and diabetes on the enteroinsular axis
Authors: Korosi, J McIntosh, CHS Pederson, RA Demuth, HU Habener, JF Gingerich, R Egan, JM Elahi, D Meneilly, GS
Citation: J. Korosi et al., Effect of aging and diabetes on the enteroinsular axis, J GERONT A, 56(9), 2001, pp. M575-M579
Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions
Authors: Hildebrandt, M Arck, PC Kruber, S Demuth, HU Reutter, W Klapp, BF
Citation: M. Hildebrandt et al., Inhibition of dipeptidyl peptidase IV (DP IV, CD26) activity abrogates stress-induced, cytokine-mediated murine abortions, SC J IMMUN, 53(5), 2001, pp. 449-454
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)
Authors: Hinke, SA Manhart, S Pamir, N Demuth, HU Gelling, RW Pederson, RA McIntosh, CHS
Citation: Sa. Hinke et al., Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP), BBA-PROT ST, 1547(1), 2001, pp. 143-155
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
Authors: Pospisilik, JA Hinke, SA Pederson, RA Hoffmann, T Rosche, F Schlenzig, D Glund, K Heiser, U McIntosh, CHS Demuth, HU
Citation: Ja. Pospisilik et al., Metabolism of glucagon by dipeptidyl peptidase IV (CD26), REGUL PEPT, 96(3), 2001, pp. 133-141
Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose
Authors: Meneilly, GS Demuth, HU McIntosh, CHS Pederson, RA
Citation: Gs. Meneilly et al., Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose, DIABET MED, 17(5), 2000, pp. 346-350
Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases
Authors: Stockel-Maschek, A Mrestani-Klaus, C Stiebitz, B Demuth, HU Neubert, K
Citation: A. Stockel-maschek et al., Thioxo amino acid pyrrolidides and thiazolidides: new inhibitors of proline specific peptidases, BBA-PROT ST, 1479(1-2), 2000, pp. 15-31
Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (beta TC-3) cells to glucose-dependent insulinotropic polypeptide
Authors: Hinke, SA Pauly, RP Ehses, J Kerridge, P Demuth, HU McIntosh, CHS Pederson, RA
Citation: Sa. Hinke et al., Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (beta TC-3) cells to glucose-dependent insulinotropic polypeptide, J ENDOCR, 165(2), 2000, pp. 281-291
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon - Characterization of glucagon degradation products and DPIV-resistant analogs
Authors: Hinke, SA Pospisilik, JA Demuth, HU Mannhart, S Kuhn-Wache, K Hoffmannn, T Nishimura, E Pederson, RA McIntosh, CHS
Citation: Sa. Hinke et al., Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon - Characterization of glucagon degradation products and DPIV-resistant analogs, J BIOL CHEM, 275(6), 2000, pp. 3827-3834
Kinetic analysis of enzymatic and nonenzymatic degradation of peptides by MALDI-TOFMS
Authors: Rosche, F Schmidt, J Hoffmann, T Pauly, RP McIntosh, CHS Pederson, RA Demuth, HU
Citation: F. Rosche et al., Kinetic analysis of enzymatic and nonenzymatic degradation of peptides by MALDI-TOFMS, METH MOL B, 146, 2000, pp. 251-272
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor ile-thiazolidide
Authors: Pauly, RP Demuth, HU Rosche, F Schmidt, J White, HA Lynn, F McIntosh, CHS Pederson, RA
Citation: Rp. Pauly et al., Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor ile-thiazolidide, METABOLISM, 48(3), 1999, pp. 385-389
Risultati: 1-11 |